We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

ExpreS2ion Biotechnologies and Cancer Research UK Enter a Licensing Agreement

News   Jun 11, 2013

 
ExpreS<sup>2</sup>ion Biotechnologies and Cancer Research UK Enter a Licensing Agreement
 
 
 

RELATED ARTICLES

Paradigm Shift for Design of Universal Vaccines

News

Killer T cells have been identified that can fight all influenza viruses – A, B and C – creating the potential for the development of a world-first universal, one-shot flu vaccine.

READ MORE

Widespread Brain Inflammation Revealed in Post-treatment Lyme Disease

News

PET scanning has shown that 12 people with documented post-treatment Lyme disease syndrome all show elevation of a chemical marker of widespread brain inflammation, compared with 19 healthy controls.

READ MORE

Rubicon Alters Autophagy in Animals During Aging

News

Rubicon is a protein factor that suppresses autophagy by controlling a specific step in this pathway. This study found that Rubicon expression levels increased in an age-related manner in worm, fly, and mouse tissues.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Genomics Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE